Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-13RAPP144KRISHNASWAMY YELESWARAM plan to sell securities of Rapport Therapeutics, Inc. under Form 144MEDIUM
KRISHNASWAMY YELESWARAM filed Form 144 to notify SEC of plan to sell 19365 units of Rapport Therapeutics, Inc. securities around 2026-04-13, with aggregate market value of $661,702.05. The total outstanding units is 47792943.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactio...
Small CapBiotechnology
2026-04-13MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 14058 units of Mineralys Therapeutics, Inc. securities around 2026-04-13, with aggregate market value of $373,086.81. The total outstanding units is 82399478.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions...
Mid CapBiotechnology
2026-04-13IRON144WILLIAM SAVAGE plan to sell securities of DISC MEDICINE INC under Form 144MEDIUM
WILLIAM SAVAGE filed Form 144 to notify SEC of plan to sell 5731 units of DISC MEDICINE INC securities around 2026-04-13, with aggregate market value of $380,079.92. The total outstanding units is 38160065.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past 3 months...
Mid CapBiotechnology